Mint Explainer: The trigger behind DGCI alert on Abbott’s Digene, Takeda's cancer jab
DCGI has issued advisories to discontinue the use of Abbott's Digene Gel, a popular antacid medication, and Takeda's Adcetris Injection for cancer treatment, citing safety concerns
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
